sudden hearing loss
Conditions
Interventions
Group A(standard treatment):Dexamethasone 10mg intravenous drip once a day for 5 days
Group B:Dexamethasone 5mg intratympanic once a day for 5 days
Group C: dexamethasone 5mg,intratympanic , qod * 5
group D:Dexamethasone 10mg,intratympanic, once a day for 5 consecutive days
Group E:Dexamethasone, 10mg intratympanic, qod*5
Group F:Methylprednisolone 20mg, intratympanic injection, qd*5
Group G:methylprednisolone20mg,intratympanic, qod*5
Group G:methylprednisolone40mg,intratympanic, qd*5
Group I :methylprednisolone40mg,intratympanic, qod*5
Sponsors
Xinhua Hospital, Medicine School of Shanghai Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. patients diagnosed as sudden hearing loss aged 18-80 years old; 2. No contraindication of intratympanic injection of glucocorticoid; 3. no tympanic perforation.
Exclusion criteria
Exclusion criteria: 1. children; 2. Combined mental and psychological diseases; 3. Patients with a clear cause of the disease; 4. To give up treatment or automatic discharge before the end of the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cure rate;Effective rate; | — |
Countries
China
Contacts
Public ContactMei Ling
Xinhua hospital affiliated to Medicine School of Shanghai Jiaotong University
Outcome results
None listed